Results 201 to 210 of about 385,298 (294)

Antimicrobial Resistance of Neisseria meningitidis in the United States, 1997 [PDF]

open access: bronze, 2000
Nancy E. Rosenstein   +4 more
openalex   +1 more source

Orally Administered Functional Polyphenol‐Nanozyme‐Armored Probiotics for Enhanced Amelioration of Intestinal Inflammation and Microbiota Dysbiosis

open access: yesAdvanced Science, EarlyView.
This study presents a novel polyphenol‐nanozyme‐armored probiotic system (ECA@EcN) for enhanced treatment of inflammatory bowel disease (IBD). By integrating chitosan‐modified epigallocatechin gallate (EGCG‐CS) with gold nanozymes, the system effectively scavenges ROS, improves probiotic viability, and restores gut microbiota balance.
Yong Zhu   +12 more
wiley   +1 more source

Sustainable solutions to the continuous threat of antimicrobial resistance. [PDF]

open access: yesHealth Aff Sch
Spellberg B   +20 more
europepmc   +1 more source

European Antimicrobial Resistance Surveillance System (EARSS): objectives and organisation

open access: diamond, 1999
S L A M Bronzwaer   +5 more
openalex   +1 more source

Low‐Irradiance Antimicrobial Blue Light‐Bathing Therapy for Wound Infection Control

open access: yesAdvanced Science, EarlyView.
Antimicrobial blue light has been shown as an appealing non‐pharmacological antimicrobial alternative. However, its clinical applications have been hindered by high irradiance‐associated photothermal risks. In this work, a low‐irradiance blue light‐bathing concept and a wearable photonic wound patch are established to address this challenge in terms of
Jie Hui   +12 more
wiley   +1 more source

Antimicrobial resistance-attributable mortality: a patient-level analysis. [PDF]

open access: yesJAC Antimicrob Resist
Baltas I   +4 more
europepmc   +1 more source

Gut Microbiota Modulation by Inulin Improves Metabolism and Ovarian Function in Polycystic Ovary Syndrome

open access: yesAdvanced Science, EarlyView.
This work proposes a novel strategy targeting gut microbiota for managing polycystic ovary syndrome (PCOS). Inulin, a gut microbiota modulator, notably boosts the growth of short‐chain fatty acids (SCFAs)‐producers, represented by Bifidobacterium, thereby improving glucolipid metabolism and ovarian function of PCOS through suppressing the inflammatory ...
Lulu Geng   +8 more
wiley   +1 more source

Rapid Raman spectroscopy-based test for antimicrobial resistance. [PDF]

open access: yesOpen Biol
Mushenkov V   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy